Non-Current Assets
Goodwill
Gilead Sciences Goodwill remained flat by 0.0% to $8.31B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $8.31B to $8.31B. Over 5 years (FY 2020 to FY 2025), Goodwill shows relatively stable performance with a 0.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
How to read this metric
High goodwill indicates a history of aggressive M&A activity; significant write-downs may signal that past acquisitions failed to meet performance expectations.
Detailed definition
This represents the premium paid over the fair market value of net assets during an acquisition. It reflects the value o...
Peer comparison
Standard across all industries; common in sectors with frequent M&A activity like pharmaceuticals.
Metric ID:
goodwillHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.33B | $8.33B | $8.33B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B | $8.31B |
| QoQ Change | — | -0.0% | +0.0% | -0.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -0.2% | -0.2% | -0.2% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
Range$8.31B – $8.33B
CAGR-0.1%
Avg YoY Growth-0.0%
Median YoY Growth+0.0%
Current Streak16 quarters growth
Goodwill at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's goodwill?
- Gilead Sciences (GILD) reported goodwill of $8.31B in Q1 2026.
- How has Gilead Sciences's goodwill changed year-over-year?
- Gilead Sciences's goodwill decreased by 0.0% year-over-year, from $8.31B to $8.31B.
- What is the long-term trend for Gilead Sciences's goodwill?
- Over 5 years (2020 to 2025), Gilead Sciences's goodwill has grown at a 0.5% compound annual growth rate (CAGR), from $8.11B to $8.31B.
- What does goodwill mean?
- The excess price paid for an acquisition over the fair value of the assets acquired.